GLP-1 agonists like semaglutide and tirzepatide slow gastric emptying by 30-40% as part of their mechanism of action (Nauck et al., Diabetologia, 2011)
Actually, no metastases were found in the experimental mice, and long-term administration of Epithalon in small doses did not show any toxic effect
So really the only so-called treatment for erectile dysfunction out there is a pill that doesn't treat anything, it just temporarily
The article in AP came out today
Pharmacokinetic characterisation is comparatively thin, but distribution and elimination have been profiled in rats and dogs in a 2023 pharmacokinetic study (PMC9794587), which is useful context because most claims about systemic healing rest on animal exposure data rather than validated human pharmacology
Knowing the actual concentration of what you're using also helps with troubleshooting